The Alzheimer’s Impact Movement (AIM) has worked with the Alzheimer's Association to propel the U.S. government to act. Our efforts have resulted in a seven-fold increase in Alzheimer's and dementia research funding since the passage of the National Alzheimer’s Project Act (NAPA). Today, funding for Alzheimer's and dementia research at the National Institutes of Health (NIH) is $3.2 billion.
As a result of this unprecedented funding, scientists are able to work at a more rapid pace to advance basic disease knowledge, explore ways to reduce risk, uncover new biomarkers for early diagnosis and drug targeting, and develop potential treatments. While much progress has been made in understanding the brain changes associated with Alzheimer’s and how the disease progresses, more research — reflective of the U.S. population — is needed. Learn how AIM is working with bipartisan Congressional leaders on the Equity in Neuroscience and Alzheimer’s Clinical Trials (ENACT) Act, which would increase the participation of underrepresented populations in Alzheimer’s and other dementia clinical trials.
Join us as we call on Congress to renew their commitment in the fight by increasing Alzheimer’s and dementia research funding at the NIH by $289 million for fiscal year 2022.
Letters-to-the-Editor (LTE) are a great way to grow support for our public policy priorities. Click below for talking points that can be used to help you write a LTE asking policymakers to support Alzheimer’s research.
With help from volunteers like you we’re making sure policymakers hear directly from people impacted by Alzheimer’s. But our work isn’t done. Join us.
Everything you need to make the most of your year around advocacy efforts are available in this Advocate’s Guide. We’ll be updating this guide throughout the year as our policy priorities are introduced in Congress.